Alzheimer's disease drug development pipeline: 2022

INTRODUCTION: Alzheimer's disease (AD) represents a global health crisis. Treatments are needed to prevent, delay the onset, slow the progression, improve cognition, and reduce behavioral disturbances of AD. We review the current clinical trials and drugs in development for the treatment of AD....

Descripción completa

Detalles Bibliográficos
Autores principales: Cummings, Jeffrey, Lee, Garam, Nahed, Pouyan, Kambar, Mina Esmail Zadeh Nojoo, Zhong, Kate, Fonseca, Jorge, Taghva, Kazem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066743/
https://www.ncbi.nlm.nih.gov/pubmed/35516416
http://dx.doi.org/10.1002/trc2.12295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066743/
https://www.ncbi.nlm.nih.gov/pubmed/35516416
http://dx.doi.org/10.1002/trc2.12295

Ejemplares similares